Although there is an important breast cancer risk reduction of between 39% (BRCA1) and 72% (BRCA2) [10] among mutation carriers who have RRSO before the age of 50 years, Domchek et al. 2010 did not find a similar reduction in women who had had prior breast cancer [8]. The gene discussed is BRCA1; the disease is breast cancer.